Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1968 2
1972 1
1975 1
1976 1
1978 1
1981 2
1982 4
1983 2
1984 1
1985 1
1996 1
2009 2
2010 1
2011 4
2012 3
2014 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Chain cystourethrogram and stress incontinence.
Kitzmiller JL, Manzer GA, Nebel WA, Lucas WE. Kitzmiller JL, et al. Among authors: nebel wa. Obstet Gynecol. 1972 Mar;39(3):333-40. Obstet Gynecol. 1972. PMID: 5063036 No abstract available.
Management of tubo-ovarian abscess.
Nebel WA, Lucas WE. Nebel WA, et al. Obstet Gynecol. 1968 Sep;32(3):382-6. Obstet Gynecol. 1968. PMID: 5742119 No abstract available.
Sepsis in abortion.
Brame RG, Nebel WA, Whiteside J. Brame RG, et al. Among authors: nebel wa. N C Med J. 1968 Feb;29(2):60-4. N C Med J. 1968. PMID: 5237456 No abstract available.
Cold knife conization of the cervix uteri.
Nebel W, Shingleton HM, Swanton MC. Nebel W, et al. Surg Gynecol Obstet. 1967 Oct;125(4):780-4. Surg Gynecol Obstet. 1967. PMID: 6041720 No abstract available.
Information and communication technologies for promoting and sustaining quality of life, health and self-sufficiency in ageing societies--outcomes of the Lower Saxony Research Network Design of Environments for Ageing (GAL).
Haux R, Hein A, Kolb G, Künemund H, Eichelberg M, Appell JE, Appelrath HJ, Bartsch C, Bauer JM, Becker M, Bente P, Bitzer J, Boll S, Büsching F, Dasenbrock L, Deparade R, Depner D, Elbers K, Fachinger U, Felber J, Feldwieser F, Forberg A, Gietzelt M, Goetze S, Gövercin M, Helmer A, Herzke T, Hesselmann T, Heuten W, Huber R, Hülsken-Giesler M, Jacobs G, Kalbe E, Kerling A, Klingeberg T, Költzsch Y, Lammel-Polchau C, Ludwig W, Marschollek M, Martens B, Meis M, Meyer EM, Meyer J, Meyer Zu Schwabedissen H, Moritz N, Müller H, Nebel W, Neyer FJ, Okken PK, Rahe J, Remmers H, Rölker-Denker L, Schilling M, Schöpke B, Schröder J, Schulze GC, Schulze M, Siltmann S, Song B, Spehr J, Steen EE, Steinhagen-Thiessen E, Tanschus NM, Tegtbur U, Thiel A, Thoben W, van Hengel P, Wabnik S, Wegel S, Wilken O, Winkelbach S, Wist T, Wolf KH, Wolf L, Zokoll-van der Laan M; Lower Saxony Research Network GAL. Haux R, et al. Among authors: nebel w. Inform Health Soc Care. 2014 Sep-Dec;39(3-4):166-87. doi: 10.3109/17538157.2014.931849. Inform Health Soc Care. 2014. PMID: 25148556
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.
Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, Garland S, Romanowski B, Aoki FY, Schwarz TF, Bosch FX, Harper DM, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group. Szarewski A, et al. Int J Cancer. 2012 Jul 1;131(1):106-16. doi: 10.1002/ijc.26362. Epub 2011 Oct 23. Int J Cancer. 2012. PMID: 21858807 Clinical Trial.
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years.
Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Meric D, Dessy FJ, Datta SK, Descamps D, Dubin G; HPV-010 Study Group. Einstein MH, et al. Hum Vaccin. 2011 Dec;7(12):1343-58. doi: 10.4161/hv.7.12.18281. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22048173 Free PMC article. Clinical Trial.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Harper DM, Huh W, Hardt K, Zahaf T, Descamps D, Struyf F, Dubin G, Lehtinen M; HPV PATRICIA Study Group. Wheeler CM, et al. Lancet Oncol. 2012 Jan;13(1):100-10. doi: 10.1016/S1470-2045(11)70287-X. Epub 2011 Nov 8. Lancet Oncol. 2012. PMID: 22075170 Clinical Trial.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group. Paavonen J, et al. Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6. Lancet. 2009. PMID: 19586656 Clinical Trial.
27 results